A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.
Clinical trial NCT06390111 · WITHDRAWN
Trial details
- NCT number
- NCT06390111
- Sponsor
- Ferring Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2026-07-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.